KSS
36
2
JPM
59
6
EW
55
5
ILMN
31
4
RL
73
5
VRSN
59
4
CME
59
3
BDX
59
3
OI
23
3
ADBE
50
3
PLD
35
5
V
70
14
EQR
33
6
MDT
59
4
AMAT
33
3
CMA
42
3
VRSK
54
2
JWN
72
9
CRM
65
6
ADT
12
2
KSS
36
2
JPM
59
6
EW
55
5
ILMN
31
4
RL
73
5
VRSN
59
4
CME
59
3
BDX
59
3
OI
23
3
ADBE
50
3
PLD
35
5
V
70
14
EQR
33
6
MDT
59
4
AMAT
33
3
CMA
42
3
VRSK
54
2
JWN
72
9
CRM
65
6
ADT
12
2
Financhill
Back

Novartis AG Vs. Monte Rosa Therapeutics Industry Stock Comparison

Sell
45

NVS
Novartis AG

Last Price:
$97.09
Seasonality Move:
-2.4%
Sell
21

GLUE
Monte Rosa Therapeutics

Last Price:
$6.92
Seasonality Move:
-3.94%
Sell
45
Novartis AG (NVS) is a Sell

Is Novartis AG a Buy, Sell or Hold?

  • The current Novartis AG [NVS] share price is $97.11. The Score for NVS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • NVS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
21
Monte Rosa Therapeutics (GLUE) is a Sell

Is Monte Rosa Therapeutics a Buy, Sell or Hold?

  • The current Monte Rosa Therapeutics [GLUE] share price is $6.91. The Score for GLUE is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • GLUE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NVS Stock Price Chart

What is Novartis AG's stock price today?

  • The Novartis AG share price today is $97.11
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVS is experiencing slight buying pressure.

GLUE Stock Price Chart

What is Monte Rosa Therapeutics's stock price today?

  • The Monte Rosa Therapeutics share price today is $6.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLUE is experiencing slight buying pressure.

NVS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.58 Sell
Relative Strength Index (14 RSI): 28.12 Sell
Chaikin Money Flow: 575307 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (98.81 - 104.37) Sell
Bollinger Bands (100): (104.41 - 117.41) Sell

GLUE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.34 Sell
Relative Strength Index (14 RSI): 39.42 Sell
Chaikin Money Flow: 968460 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.45 - 9.53) Sell
Bollinger Bands (100): (4.82 - 8.52) Buy

NVS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 97.96 Sell
20-day SMA: 101.17 Sell
50-day SMA: 106.4 Sell
200-day SMA: 106.33 Sell
8-day EMA: 98.2 Sell
20-day EMA: 100.59 Sell
50-day EMA: 104.83 Sell
200-day EMA: 106.54 Sell

GLUE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.46 Sell
20-day SMA: 8.59 Sell
50-day SMA: 7.94 Sell
200-day SMA: 5.93 Buy
8-day EMA: 7.49 Sell
20-day EMA: 8.11 Sell
50-day EMA: 7.84 Sell
200-day EMA: 6.37 Buy

Novartis AG Earnings Growth & NVS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.95 per share, and an increase next year of $0.72 per share.

Monte Rosa Therapeutics Earnings Growth & GLUE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and a decrease next year of $0.60 per share.

Novartis AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monte Rosa Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):